Ovine Herpesvirus 1: Veterinary Reference

Taxonomy and Genomic Organization of Ovine Herpesvirus 1

Ovine herpesvirus 1 (OvHV-1) occupies a distinctive and clinically critical position within the Herpesviridae family, a large and diverse assemblage of enveloped, double-stranded DNA viruses that infect a broad range of vertebrate hosts. The precise taxonomic classification of OvHV-1 is essential for understanding its evolutionary relationships, pathogenic mechanisms, and epidemiological behavior. According to the most recent taxonomic framework established by the International Committee on Taxonomy of Viruses (ICTV), OvHV-1 is classified within the subfamily Gammaherpesvirinae, genus Macavirus [3, 4]. This placement is not merely a matter of nomenclature; it carries profound implications for the virus’s biology, host range, and disease associations. The genus Macavirus is a group of gammaherpesviruses that are characteristically associated with lymphoproliferative diseases and are known to establish latent infections in lymphocytes, particularly in lymphoid tissues [3, 4]. The members of this genus are further distinguished by their capacity to cause malignant catarrhal fever (MCF), a severe, often fatal, systemic disease affecting a wide range of ungulates, including cattle, bison, deer, and pigs [4, 7]. The MCF virus (MCFV) group, which includes OvHV-2, alcelaphine gammaherpesvirus 1 (AlGHV-1), and caprine gammaherpesvirus 2 (CpGHV-2), is a subset of the Macavirus genus, and OvHV-1 is a member of this group [3, 4]. The distinction between OvHV-1 and OvHV-2, while both are ovine gammaherpesviruses, is a critical point of clarification. OvHV-2 is the primary etiological agent of sheep-associated MCF (SA-MCF), a disease of significant economic and animal welfare concern globally [4, 7]. In contrast, OvHV-1, while also a Macavirus, has been less definitively linked to clinical MCF, though its presence in tissues of aborted fetuses and its phylogenetic proximity to other MCFV members suggest a potential, albeit less characterized, pathogenic role [3].

Taxonomic Hierarchy and Phylogenetic Context

The taxonomic hierarchy of OvHV-1 is as follows: Order Herpesvirales, Family Herpesviridae, Subfamily Gammaherpesvirinae, Genus Macavirus, Species Ovine herpesvirus 1. This classification is supported by phylogenetic analyses of conserved viral genes, such as the DNA polymerase gene, which consistently place OvHV-1 within the Macavirus clade [3]. The genus Macavirus itself is a monophyletic group that includes, in addition to OvHV-1 and OvHV-2, bovine gammaherpesvirus 6 (BoGHV-6), alcelaphine gammaherpesvirus 1 (AlGHV-1), and porcine lymphotropic herpesvirus (PLHV) [3]. The evolutionary relationships within this genus are complex and reflect a long history of co-evolution with their respective mammalian hosts. Phylogenetic analyses have demonstrated that OvHV-1 is more closely related to OvHV-2 and AlGHV-1 than to BoGHV-6 or PLHV, a finding that is consistent with the known host range and disease associations of these viruses [3]. For instance, a study examining the polymerase gene of BoGHV-6 revealed that it shares 72.2–73.3% nucleotide identity with members of the MCFV group, including OvHV-1, while being 67.4–68.2% identical to PLHV [3]. This level of divergence underscores the distinct evolutionary trajectories of these viruses within the Macavirus genus. The phylogenetic tree of the Macavirus genus is further refined by analyses of other genomic regions, such as the glycoprotein B (gB) and tegument protein genes, which provide additional resolution for distinguishing between closely related species [8]. The use of multiple genetic markers is crucial for robust phylogenetic inference, as single-gene analyses can sometimes be misleading due to recombination or convergent evolution.

Genomic Organization: Structure and Architecture

The genome of OvHV-1, like all herpesviruses, is a linear, double-stranded DNA molecule. While the complete genome sequence of OvHV-1 has not been fully assembled and published in the same detail as some other herpesviruses (e.g., bovine herpesvirus 1 or equine herpesvirus 1), the available data from partial genomic sequences and comparative analyses with other Macavirus members provide a clear picture of its overall organization. The genome is estimated to be approximately 130–160 kilobase pairs (kbp) in length, a size range typical of gammaherpesviruses [3, 4]. The genomic architecture is characterized by a unique long (UL) region and a unique short (US) region, each flanked by inverted repeat sequences. This structural arrangement is a hallmark of the Herpesviridae family and is critical for viral replication, recombination, and the generation of genomic isomers. The repeat sequences, often designated as terminal repeats (TR) and internal repeats (IR), are involved in the circularization of the genome during latency and in the packaging of the genome into virions. The precise arrangement and size of these repeats in OvHV-1 are not fully defined, but they are likely similar to those observed in other Macavirus genomes, such as AlGHV-1 and OvHV-2.

The genome encodes for a repertoire of approximately 70–100 open reading frames (ORFs), which are organized into several functional gene blocks. These blocks are conserved across the Herpesviridae family and include genes involved in DNA replication, nucleotide metabolism, capsid assembly, tegument formation, envelope glycoprotein synthesis, and immune evasion. The core replication machinery includes the DNA polymerase (UL30 homolog), the helicase-primase complex (UL5, UL8, UL52 homologs), and the single-stranded DNA-binding protein (UL29 homolog). The nucleotide metabolism genes, such as thymidine kinase (TK) and ribonucleotide reductase, are essential for providing a pool of deoxyribonucleotide triphosphates (dNTPs) for viral DNA synthesis, particularly in non-dividing cells. The TK gene, in particular, has been a target for molecular detection and phylogenetic analysis of OvHV-1, as it is relatively conserved among herpesviruses [1, 2]. The structural proteins of the virion are encoded by genes that are organized in a conserved manner. The capsid is composed of major and minor capsid proteins, which form an icosahedral shell that encloses the viral genome. The tegument, a proteinaceous layer between the capsid and the envelope, contains a variety of proteins that are involved in the early stages of infection, including the modulation of host cell signaling and the transport of the viral genome to the nucleus. The envelope is studded with glycoproteins, such as gB, gC, gD, gH, and gL, which are critical for viral attachment, entry, and cell-to-cell spread. The gB gene, in particular, is highly conserved and has been used extensively for phylogenetic studies of herpesviruses, including OvHV-1 [2, 8]. The glycoproteins are also major targets for the host immune response and are therefore important for vaccine development.

The Macavirus Genomic Signature: Conserved Features and Unique Elements

A defining feature of the Macavirus genus, and by extension OvHV-1, is the presence of a specific set of genes that are associated with the pathogenesis of MCF. These include genes encoding for a viral interleukin-10 (vIL-10) homolog, a viral bcl-2 (vBcl-2) homolog, and a viral chemokine receptor (vCCR) homolog. These genes are thought to be involved in the manipulation of the host immune response, promoting the survival and proliferation of infected lymphocytes, and contributing to the lymphoproliferative and inflammatory lesions characteristic of MCF [4]. The vIL-10 homolog, for example, can suppress the host’s antiviral immune response by inhibiting the production of pro-inflammatory cytokines and the activation of T cells. The vBcl-2 homolog can inhibit apoptosis, allowing infected cells to survive and proliferate. The vCCR homolog can bind to host chemokines, potentially altering the trafficking of immune cells to sites of infection. The presence and sequence of these genes are key diagnostic and phylogenetic markers for distinguishing between different Macavirus species. For instance, the vIL-10 gene of OvHV-2 has been shown to be highly divergent from that of AlGHV-1, reflecting the different host ranges and pathogenic profiles of these viruses. The genomic organization of these immune evasion genes is often clustered in a specific region of the genome, known as the “MCF-specific” region, which is a hallmark of the Macavirus genus.

Comparative Genomics: OvHV-1 in the Context of Other Herpesviruses

Comparative genomic analyses of OvHV-1 with other herpesviruses, both within the Gammaherpesvirinae subfamily and across the Herpesviridae family, reveal both conserved and unique features. At the level of the entire genome, the organization of the core gene blocks is highly conserved, reflecting the common ancestry of all herpesviruses. However, the specific sequences of these genes, particularly those encoding surface glycoproteins and immune evasion molecules, are highly variable, reflecting the adaptation of each virus to its specific host and ecological niche. For example, the gB gene of OvHV-1 shares a high degree of sequence similarity with that of OvHV-2 and AlGHV-1, but is more divergent from the gB genes of alphaherpesviruses, such as bovine herpesvirus 1 (BoHV-1) or equine herpesvirus 1 (EHV-1) [5, 8]. This is consistent with the phylogenetic placement of OvHV-1 within the Gammaherpesvirinae subfamily. The TK gene, which is a common target for PCR-based detection, also shows a similar pattern of conservation within the Macavirus genus [1, 2]. The use of these conserved genes for phylogenetic analysis has been instrumental in confirming the taxonomic status of OvHV-1 and in tracing the evolutionary history of the Macavirus genus. The availability of complete genome sequences for other Macavirus members, such as AlGHV-1 and OvHV-2, has provided a valuable framework for understanding the genomic organization of OvHV-1. These genomes have been shown to be collinear, meaning that the order of the core gene blocks is largely conserved, with variations occurring primarily in the terminal and internal repeat regions and in the regions encoding the MCF-specific genes.

Implications for Pathogenesis and Diagnosis

The taxonomic and genomic characteristics of OvHV-1 have direct implications for understanding its pathogenesis and for developing diagnostic tools. As a Macavirus, OvHV-1 is expected to establish latency in lymphocytes, particularly in B cells and T cells, and to reactivate under conditions of stress or immunosuppression [3, 4]. The presence of the MCF-specific genes, such as vIL-10 and vBcl-2, suggests that OvHV-1 has the potential to cause lymphoproliferative disease, although the clinical evidence for this is less robust than for OvHV-2 [4]. The detection of OvHV-1 DNA in tissues of aborted fetuses, often in the context of co-infections with other pathogens, suggests that it may play a role in reproductive disease, though the exact mechanism remains to be elucidated [3]. The genomic organization of OvHV-1 also informs the design of diagnostic assays. PCR-based detection methods, which target conserved genes such as the polymerase gene or the TK gene, are the most sensitive and specific tools for detecting OvHV-1 infection [3, 7]. Real-time PCR assays, such as TaqMan-based methods, can provide quantitative data on viral load, which may be useful for monitoring disease progression or the response to treatment [6]. The development of serological assays, such as ELISA, for the detection of antibodies against OvHV-1 is more challenging due to the antigenic cross-reactivity among Macavirus members. However, the identification of unique epitopes on the glycoproteins of OvHV-1 could lead to the development of more specific serological tests. The World Organisation for Animal Health (WOAH) recognizes MCF as a notifiable disease, and the accurate diagnosis of OvHV-1 infection is crucial for implementing effective control measures, particularly in regions where sheep and cattle are raised in close proximity [7]. The genomic data also provide a foundation for the development of vaccines, although no commercial vaccine is currently available for OvHV-1. The identification of conserved and immunogenic proteins, such as gB and gD, could be used to design subunit or vectored vaccines that could protect against infection or reduce viral shedding.

Molecular Pathogenesis and Virulence Factors

Ovine herpesvirus 2 (OvHV-2), the etiological agent of sheep-associated malignant catarrhal fever (SA-MCF), represents one of the most enigmatic and pathobiologically complex members of the Gammaherpesvirinae subfamily, genus Macavirus [4]. Unlike many herpesviruses that cause direct cytopathic effects in their target cells, OvHV-2 orchestrates a profound immunopathological disease characterized by the uncontrolled proliferation and tissue infiltration of CD8+ T lymphocytes [4]. This section provides an exhaustive analysis of the molecular mechanisms by which OvHV-2 establishes infection, evades host immunity, and triggers the fatal lymphoproliferative syndrome known as MCF.

Genomic Organization and Virion Architecture

OvHV-2 possesses a large double-stranded DNA genome characteristic of the Gammaherpesvirinae, encoding approximately 70-80 open reading frames (ORFs). The viral genome is housed within an icosahedral capsid, surrounded by a proteinaceous tegument layer and a lipid envelope studded with glycoproteins essential for host cell entry. Critical structural proteins include glycoprotein B (gB), glycoprotein D (gD), and the thymidine kinase (TK) enzyme, which are conserved across the Herpesviridae family and serve as targets for both diagnostic molecular detection and phylogenetic characterization. Comparative genomic analyses have revealed that OvHV-2 shares significant nucleotide homology with other macaviruses, including alcelaphine herpesvirus 1 (AlHV-1), bovine gammaherpesvirus 6 (BoGHV6), and caprine herpesvirus 2 (CpGHV2), with the polymerase gene demonstrating 72.2-73.3% divergence from the MCF virus group [3]. This genetic relatedness underscores the evolutionary conservation of core replicative machinery while also explaining the cross-species transmission potential that underpins MCF epidemiology.

Molecular Pathogenesis: The Immunopathological Paradox

The central paradox of OvHV-2 pathogenesis lies in the virus's ability to induce a fatal, systemic lymphoproliferative disease in susceptible ungulates (primarily cattle, cervids, and pigs) while maintaining a completely asymptomatic, persistent infection in its natural ovine reservoir host [4, 7]. In sheep, OvHV-2 establishes lifelong latency, with periodic reactivation and shedding, particularly in nasal secretions of lambs, without eliciting clinical disease. The molecular basis for this species-specific pathogenesis remains incompletely understood, but emerging evidence points to a delicate interplay between viral immunomodulatory genes and host immune surveillance mechanisms.

Upon transmission from sheep to susceptible species, OvHV-2 initiates a cascade of events that culminates in the massive, uncontrolled proliferation of CD8+ T lymphocytes. This phenomenon is not due to direct viral replication within these cells, as OvHV-2 DNA is detectable in lymphoblastoid cell lines from affected animals, yet infectious virus cannot be recovered [4]. Instead, the pathogenesis is driven by viral proteins that subvert normal T-cell homeostasis. The viral genome encodes homologs of cellular signaling molecules, including a putative viral interleukin-10 (vIL-10) and a viral FLICE-inhibitory protein (vFLIP), which are thought to promote lymphocyte survival and proliferation while preventing apoptosis. These viral analogs hijack the host's cytokine signaling pathways, creating a milieu that favors the expansion of virus-infected or virus-activated T cells.

The resulting CD8+ T cell infiltrates accumulate in a wide array of tissues, including the liver, kidney, lung, brain, and gastrointestinal tract, leading to the characteristic histopathological lesions of MCF: lymphocytic vasculitis, epithelial necrosis, and fibrinoid necrosis of small arteries [7]. The "head and eye" form of MCF, with its conjunctivitis, corneal edema, nasal discharge, and oral ulcerations, reflects the particular tropism of these infiltrating lymphocytes for mucosal surfaces and ocular tissues. Notably, the alimentary tract form, characterized by severe diarrhea and dysentery, has been increasingly recognized in herd outbreaks, such as the Cumbrian outbreak where eight housed dairy cows exhibited hemorrhagic enteritis as the predominant clinical manifestation [7]. This variability in clinical presentation likely reflects differences in the homing receptors expressed on the expanding CD8+ T cell clones and the local tissue microenvironment that dictates lymphocyte trafficking.

Virulence Factors and Genetic Determinants

While the complete repertoire of OvHV-2 virulence factors has not been fully elucidated, comparative genomics with other gammaherpesviruses and targeted molecular analyses have identified several key determinants of pathogenicity.

Glycoprotein B (gB): This highly conserved envelope glycoprotein is essential for viral entry, mediating membrane fusion during attachment and penetration. In related herpesviruses, gB is a major target of neutralizing antibodies and plays a critical role in cell-to-cell spread. Sequence analysis of gB genes from field isolates has demonstrated 99-100% nucleotide homology with reference strains, indicating that this protein is under strong purifying selection and likely essential for viral fitness [2]. However, the specific role of OvHV-2 gB in T-cell tropism remains unexplored.

Glycoprotein D (gD): In alphaherpesviruses, gD serves as the receptor-binding protein, interacting with cellular entry mediators such as nectin-1 and HVEM. The existence and function of a gD homolog in OvHV-2 are less well-defined, but given the requirement for receptor-mediated entry in all herpesviruses, a gD-like function is likely present. Amino acid analysis of gD sequences from circulating strains has revealed occasional substitutions that may affect receptor binding affinity or antigenicity, potentially influencing host range or tissue tropism [2].

Thymidine Kinase (TK): The TK gene is a cornerstone of herpesvirus nucleotide metabolism, enabling viral DNA replication in quiescent cells by phosphorylating thymidine to thymidine monophosphate. In OvHV-2, the TK gene serves as a reliable target for PCR-based diagnostics, with detection rates of 21.5% in clinically affected populations [2]. Importantly, TK has been shown to possess an N-linked glycosylation site in all examined protein sequences [2], which may influence protein stability, immunogenicity, or enzymatic activity. Mutations in TK have been associated with altered pathogenicity in other herpesviruses, and while specific OvHV-2 TK mutants have not been characterized, this gene represents a potential target for antiviral therapy.

Viral Interleukin-10 (vIL-10) and vFLIP: These immunomodulatory proteins are signature virulence factors of gammaherpesviruses. vIL-10 mimics the immunosuppressive effects of cellular IL-10, downregulating pro-inflammatory cytokine production and inhibiting antigen presentation, thereby facilitating immune evasion. vFLIP, by contrast, inhibits death receptor-mediated apoptosis by blocking caspase-8 activation, promoting the survival of infected lymphocytes. The combined action of these factors likely contributes to the accumulation of CD8+ T cells in target tissues and the persistent nature of MCF.

Latency-Associated Genes: The maintenance of lifelong latency in sheep is dependent on a set of latency-associated transcripts and proteins that silence lytic gene expression while maintaining the viral episome. While the specific latency program of OvHV-2 has not been fully characterized, studies of related gammaherpesviruses suggest that latency is established in CD4+ and CD8+ T cells, with periodic reactivation triggered by stress, immunosuppression, or hormonal changes. In sheep, reactivation typically occurs in lambs between 4-9 months of age, coinciding with the peak of MCF transmission to cattle [7].

Evasion of Host Immune Responses

OvHV-2 employs multiple sophisticated strategies to evade host immune detection, a necessity for establishing persistent infection in the reservoir host and causing immunopathology in susceptible species.

Antigenic Variation: While the TK, gB, and gD genes are highly conserved, minor amino acid substitutions have been documented among field isolates [2]. These substitutions may alter epitope presentation, allowing the virus to escape neutralizing antibody responses. The potential for antigenic drift, even if small, complicates vaccine development, as current vaccines targeting AlHV-1 have shown only variable success in preventing WA-MCF and are not cross-protective against OvHV-2 [4].

Immune Modulation of T-Cell Responses: The vIL-10 homolog impairs the function of dendritic cells and macrophages, reducing their ability to present viral antigens to CD4+ T helper cells. This crippling of the adaptive immune response allows OvHV-2 to replicate and spread in the face of an otherwise competent immune system. Furthermore, the virus may directly infect and deplete CD8+ T cells in the reservoir host, preventing effective cytotoxic T lymphocyte (CTL) responses.

Latency and Reactivation Control: The establishment of latency in lymphocytes allows OvHV-2 to persist in a transcriptionally silent state, minimizing the production of antigenic viral proteins. Reactivation is tightly regulated by host transcription factors and stress hormones, ensuring that viral shedding occurs at times when transmission is most likely (e.g., during lambing and weaning). The molecular switch controlling the lytic-latent decision remains a major research focus.

Transmission Dynamics and Molecular Epidemiology

From a molecular epidemiological perspective, OvHV-2 is transmitted primarily through nasal secretions from sheep to susceptible hosts via aerosol or direct contact [4, 7]. The virus can survive in the environment for limited periods, but transmission typically requires close proximity. The seasonal pattern of MCF diagnoses, peaking in spring, correlates with the increased likelihood of contact between sheep and cattle during lambing and pasture turnout [7]. Molecular detection using nested PCR targeting the polymerase or tegument protein genes has become the gold standard for diagnosis, with viral DNA detectable in blood, spleen, and affected tissues [3, 4].

Interestingly, OvHV-2 DNA has been detected in bovine fetuses, suggesting the possibility of vertical transmission [3]. In a study of aborted dairy fetuses, OvHV-2 was identified in 76.9% of cases, often concomitantly with Histophilus somni and other abortifacient agents [3]. This finding raises the possibility that OvHV-2 may contribute to fetal death and abortion, either directly or by potentiating co-infections. However, the mere detection of viral DNA does not establish causation, and experimental studies are needed to confirm a role for OvHV-2 in bovine reproductive failure.

Host Genetic Susceptibility

The outcome of OvHV-2 infection is profoundly influenced by host genetics. While sheep are universally susceptible to infection, only a subset of cattle exposed to the virus develop clinical MCF, suggesting that host genetic factors modulate disease progression. Genome-wide association studies in sheep have identified loci on chromosomes 1, 9, and 10 that are associated with monocyte counts and immune function [10]. These loci include genes such as KCNK9, involved in cytokine production, LYD6, a marker of monocyte lineage commitment, and HMGN1, a chromatin regulator influencing myeloid differentiation [10]. Although these studies were not directly focused on OvHV-2, they highlight the genetic architecture of the ovine immune system and its potential relevance to viral pathogenesis. Understanding why some cattle resist MCF despite exposure could inform breeding strategies for resistance.

Comparative Molecular Pathogenesis with Other Macaviruses

OvHV-2 is one of six macaviruses known to cause clinical MCF, alongside AlHV-1 (wildebeest-associated MCF), caprine herpesvirus 2 (CpGHV-2), and porcine lymphotropic herpesvirus (PLHV) [3, 4]. The molecular pathogenesis of these viruses shares common features: all induce a lymphoproliferative disease characterized by CD8+ T cell infiltration and vasculitis. However, important differences exist. AlHV-1 can be isolated in cell culture and has been used to develop an attenuated vaccine for wildebeest-associated MCF, while OvHV-2 has never been successfully propagated in vitro [4]. This fundamental difference reflects unique aspects of OvHV-2's replicative biology, possibly related to its requirement for a cellular factor present only in the sheep host.

BoGHV6, a related macavirus, has been detected in tissues of aborted bovine fetuses but is not associated with clinical MCF [3]. The molecular basis for this lack of pathogenic potential remains unknown, but it may involve differences in the expression of vIL-10 or vFLIP homologs, or variations in the latency reactivation program.

Diagnostic and Molecular Detection Considerations

Accurate diagnosis of OvHV-2 infection relies on molecular detection of viral DNA. Nested PCR targeting the polymerase gene has high sensitivity and specificity, and digital droplet PCR (ddPCR) offers superior quantification compared to conventional qPCR [3, 9]. The development of multiplex assays capable of simultaneously detecting OvHV-2, BoHV-1, and other respiratory pathogens would greatly enhance surveillance efforts. For ovine samples, detection of OvHV-2 DNA in nasal secretions or blood of clinically normal sheep confirms the carrier state, while detection in affected cattle with compatible clinical signs and histopathology confirms SA-MCF diagnosis [4, 7].

Future Directions in Molecular Pathogenesis Research

The molecular pathogenesis of OvHV-2 remains one of the most significant gaps in veterinary herpesvirology. Critical unanswered questions include:

• The identity of the cellular receptor(s) used by OvHV-2 for entry into T lymphocytes
• The specific viral proteins responsible for CD8+ T cell proliferation and homing to target tissues
• The molecular determinants of latency reactivation in the ovine reservoir host
• The role of co-infections (e.g., with pestiviruses, H. somni) in modulating disease severity [3, 7]
• The potential for developing a reverse genetics system to manipulate the OvHV-2 genome

Addressing these questions will require investment in ovine experimental models, advanced molecular techniques such as single-cell RNA sequencing to characterize the transcriptional profile of infiltrating T cells, and comparative genomics of OvHV-2 strains from different geographic regions. Such studies are essential for the development of effective vaccines, antiviral therapies, and control strategies for this devastating disease.

Epidemiology and Global Distribution in Ovine Populations

The epidemiological landscape of Ovine Herpesvirus 1 (OvHV-1) is inextricably linked to its taxonomic position within the Macavirus genus of the subfamily Gammaherpesvirinae, a group that includes the causative agents of malignant catarrhal fever (MCF) [4]. Understanding the global distribution and prevalence of OvHV-1 in sheep populations requires a nuanced appreciation of its biological behavior as a subclinical, life-long infection in its reservoir host, domestic sheep (Ovis aries), contrasted with its devastating, often fatal, pathogenesis in clinically susceptible species such as cattle, bison, deer, and pigs [4, 7]. The virus is not merely a pathogen of sheep; rather, sheep serve as the primary, asymptomatic reservoir from which spillover events into highly susceptible ungulates occur, making the epidemiology of OvHV-1 a study of host-pathogen dynamics at the interface of reservoir and dead-end hosts.

Global Prevalence and Reservoir Dynamics in Sheep

The global distribution of OvHV-1 is considered ubiquitous, mirroring the worldwide distribution of domestic sheep. Serological and molecular surveys consistently demonstrate that the vast majority of sheep flocks are endemically infected, with within-flock seroprevalence often approaching 100% in adult animals. This near-universal infection is a hallmark of a well-adapted gammaherpesvirus that has co-evolved with its ovine host. The virus establishes latency, primarily in lymphocytes, and is periodically reactivated and shed, particularly in nasal secretions of lambs. This pattern of transmission is critical: lambs typically become infected within the first few months of life, often from their dams or other adult sheep, establishing a cycle of infection that perpetuates the virus within the flock without causing overt clinical disease in the reservoir species [4, 7].

The epidemiological significance of this near-universal carriage cannot be overstated. In the context of global livestock production, any region with a significant sheep population must be considered a potential source of OvHV-2 (the specific macavirus responsible for sheep-associated MCF, SA-MCF). The virus's presence is not a matter of sporadic outbreaks but a constant, underlying reality. For instance, surveillance data from the United Kingdom, as reported by the Animal and Plant Health Agency (APHA), consistently identifies OvHV-2 as the cause of MCF outbreaks in cattle, with diagnoses peaking in the spring, a period coinciding with lambing and increased viral shedding from lambs [7]. This temporal pattern underscores the direct link between the reservoir host's reproductive cycle and the risk of transmission to susceptible species.

Transmission Dynamics and Risk Factors for Spillover

The primary route of OvHV-2 transmission from sheep to susceptible hosts is via the respiratory route, through inhalation of aerosolized virus. The virus is shed in high concentrations in the nasal secretions of lambs, which act as the primary amplifiers of the virus within a flock [4, 7]. The risk of spillover is therefore highest when there is close, direct, or indirect contact between sheep and susceptible species. This is particularly pronounced during lambing season, when viral shedding is at its peak, and in management systems where sheep and cattle are co-mingled or housed in close proximity.

A compelling case study from Cumbria, UK, reported in 2018, illustrates this dynamic. An outbreak of MCF in a dairy herd affected eight adult cows, with clinical signs predominantly involving the alimentary tract, dysentery and rapid death, rather than the classic "head and eye" form. The epidemiological investigation revealed that lambs were housed in a building adjoining the milking cows [7]. This spatial proximity, combined with the high viral load shed by the lambs, created a perfect storm for aerosol transmission. The report emphasizes that preventing such transmission is exceptionally difficult, as the virus can be carried on dust and aerosols, and disease can even occur on farms without sheep if the virus is carried by fomites or wind [7]. This highlights a critical point: the epidemiology of OvHV-1 is not confined to farms with mixed livestock; it is a landscape-level risk, particularly in regions with dense sheep populations.

Geographic Distribution and Strain Variation

While OvHV-2 is considered a single virus species, molecular epidemiological studies have begun to reveal genetic diversity that may influence virulence and host range. The virus has never been successfully isolated in cell culture from affected animals; diagnosis relies on PCR detection of viral DNA, typically targeting conserved genes such as the tegument protein gene or the polymerase gene [4]. Phylogenetic analyses of these conserved regions generally show a high degree of homology among OvHV-2 strains circulating globally, suggesting a relatively stable viral genome. However, subtle genetic variations have been documented. For example, studies on related macaviruses, such as bovine gammaherpesvirus 6 (BoGHV6), have shown that strains from different geographic regions (e.g., Brazil) can share 100% nucleotide identity with wild-type strains but differ from reference strains by 0.2% [3]. This level of conservation is typical for a well-adapted, latent virus.

The global distribution of OvHV-2 is not uniform in terms of clinical impact. In regions where sheep and cattle have co-existed for centuries, such as parts of Europe, the disease is often sporadic, affecting single animals within a herd [7]. In contrast, in areas where sheep are introduced to naive populations of highly susceptible wildlife or livestock, the consequences can be catastrophic. For instance, the introduction of OvHV-2 to populations of bison in North America or to certain deer species in Asia has led to high-mortality outbreaks. The World Organization for Animal Health (WOAH) recognizes MCF as a notifiable disease due to its severe economic impact on the cattle and bison industries, and its presence can significantly constrain international trade in livestock and germplasm.

The Role of Sheep in the Broader Macavirus Ecology

The epidemiology of OvHV-1 must be understood within the broader context of the Macavirus genus. Other members, such as alcelaphine herpesvirus 1 (AlHV-1) in wildebeest and caprine herpesvirus 2 (CpHV-2) in goats, cause similar disease patterns in their respective reservoir and susceptible hosts [3, 4]. This shared biology underscores a fundamental principle: these viruses are exquisitely adapted to their reservoir hosts, causing no disease, but are highly pathogenic when they cross species barriers. The global distribution of OvHV-2 is therefore a direct consequence of the global distribution of its reservoir host, Ovis aries.

Furthermore, the potential for other ovine viruses to complicate the epidemiological picture should be considered. While OvHV-2 is the primary macavirus of concern in sheep, other viruses, such as ovine kobuvirus, have been detected in healthy sheep populations at high prevalence (62.5% in one Hungarian study), raising questions about co-infections and their impact on viral shedding or host immunity [12]. Similarly, the presence of other pathogens like Coxiella burnetii (the agent of Q fever) in ovine placentas, with prevalence rates of 26% in abortion cases in the Netherlands, highlights the complex microbial ecology of sheep and the potential for multiple pathogens to be transmitted simultaneously [11]. This is particularly relevant for public health, as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) recognize Q fever as a significant zoonotic risk, with sheep serving as a major reservoir [11].

Conclusion of the Section

In summary, the epidemiology of Ovine Herpesvirus 1 (OvHV-2) is defined by its near-ubiquitous, asymptomatic carriage in its ovine reservoir host, leading to a global distribution that mirrors that of domestic sheep. The primary epidemiological driver is the transmission of the virus from shedding lambs to susceptible species, with the risk of spillover being highest during lambing season and in management systems that allow for close contact between sheep and cattle, bison, or deer. While the viral genome is highly conserved, subtle variations exist, and the clinical impact of spillover events varies dramatically depending on the susceptibility of the exposed population. Understanding these dynamics is essential for implementing effective biosecurity measures, such as separating lambing ewes from susceptible livestock and managing shared airspace, to mitigate the significant economic losses associated with sheep-associated malignant catarrhal fever.

Clinical Manifestations and Pathological Lesions

Ovine herpesvirus 2 (OvHV-2), the etiological agent of sheep-associated malignant catarrhal fever (SA-MCF), induces a complex, multisystemic disease characterized by profound lymphoproliferation and widespread vasculitis. The clinical manifestations are notoriously variable, earning MCF the designation of a "great imitator" in veterinary medicine, with forms ranging from peracute death to chronic, indolent disease [4, 7]. The pathological hallmark is a nonsuppurative vasculitis with lymphocytic infiltration of multiple organ systems, driven by an aberrant, virus-specific CD8+ T-cell proliferation that is central to the immunopathogenesis [4]. This dysregulated immune response, rather than direct viral cytolysis, is responsible for the tissue damage observed. It is critical to recognize that while sheep are the asymptomatic reservoir host, clinical disease is almost exclusively observed in zoologically distinct, susceptible species, most notably cattle, but also deer, bison, and water buffalo, following transmission of OvHV-2 via nasal secretions, aerosols, or fomites [4, 7]. The virus itself has never been successfully cultured in vitro from affected animals; diagnosis relies on detection of OvHV-2-specific DNA in tissues or blood [4].

Clinical Syndromes

The clinical course of SA-MCF can be categorized into several overlapping syndromes, with the "head and eye" form being the most commonly recognized.

The Peracute Form: This is the most rapidly fatal manifestation, often observed in outbreaks where susceptible animals experience a massive viral challenge. Affected animals may die within 24-72 hours of the onset of clinical signs, often without showing characteristic lesions [7]. Clinical signs are nonspecific and include profound depression, high fever (40-42°C), and acute dysentery. As documented in a notable outbreak in Cumbria, UK, the first indication of disease was a collapsed adult dairy cow exhibiting severe dysentery, followed by rapid death of two others within the same group [7]. In such cases, the pathological findings can be misleading, with postmortem examination revealing only acute enteritis and hemorrhagic typhlocolitis, which may initially be mistaken for salmonellosis or other enteric pathogens [7].

The "Head and Eye" Form: This classical presentation is characterized by a constellation of signs reflecting the systemic vasculitis. The onset is typically 7-14 days post-exposure. Ocular signs are prominent and include severe bilateral conjunctivitis with chemosis, photophobia, and serous to mucopurulent ocular discharge. Corneal edema and opacity can progress to superficial ulceration [4, 7]. Oral and nasal mucosal involvement is severe, manifesting as hyperemia, erosions, and ulcerations of the gums, hard palate, tongue, and nasal turbinates. The muzzle may become crusted and exudative. Affected animals often show marked salivation and nasal discharge. The "head and eye" form derives its name from the striking bilateral ocular and oral erosive lesions [7]. These mucosal lesions are a direct result of ischemic necrosis secondary to small-vessel lymphocytic vasculitis [4].

The Alimentary Form: While dysentery can occur in the peracute form, a distinct alimentary syndrome is increasingly recognized, particularly in herd outbreaks. In these cases, the primary clinical signs are related to the gastrointestinal tract. Animals present with severe, profuse, watery diarrhea, often containing blood and mucus (dysentery), reflecting the development of hemorrhagic typhlocolitis and caecal inflammation [7]. Anorexia, rapid weight loss, and severe dehydration accompany the enteritis. In the Cumbrian outbreak, the initial animal "collapsed and died exhibiting dysentery," and postmortem examination of another animal revealed "caecal inflammation with bloody contents" alongside more typical MCF lesions of conjunctival and oral ulceration [7]. This form must be differentiated from other causes of acute diarrhea in cattle, such as bovine viral diarrhea virus (BVDV) or Salmonella spp. infection. The alimentary form appears to be a more common manifestation of herd-level outbreaks, often occurring in the spring months when contact between sheep and cattle is highest [7].

The Neurological Form: A less common but diagnostically challenging presentation involves central nervous system (CNS) signs. Animals may exhibit ataxia, incoordination, muscle tremors, nystagmus, hyperesthesia, or even recumbency with paddling movements. This form can occur in isolation or concurrently with other clinical forms. The neurological signs result from lymphocytic infiltration and perivascular cuffing in the meninges and brain parenchyma, leading to a nonsuppurative meningoencephalitis [3, 4]. The clinical picture can resemble other encephalitides, including listeriosis, rabies, or thiamine deficiency.

Pathological Lesions

The macroscopic and microscopic lesions of SA-MCF reflect the fundamental pathogenic process: a systemic, lymphoproliferative, and vasculitic syndrome.

Macroscopic (Gross) Lesions: The most characteristic findings are observed in the head region. The nasal and oral mucosa are intensely congested, with multifocal to confluent erosions and ulcerations. The conjunctiva is similarly inflamed, with corneal opacity and ulceration [7]. The alimentary tract is frequently affected; the small and large intestines may show congestion, with the cecum and colon bearing the brunt of the pathology, appearing hemorrhagic with a thickened, edematous wall and intraluminal bloody contents [7]. Lymph nodes, particularly the submandibular, retropharyngeal, and mesenteric nodes, are markedly enlarged (lymphadenomegaly), often 2-3 times their normal size, and appear edematous or hemorrhagic on cut surface. This reflects the intense lymphoproliferation [4]. In some cases, discrete lymphocytic nodules may be observed in the liver, kidneys, and myocardium. The urinary bladder often shows petechial hemorrhages (a "red pepper" appearance) due to hemorrhagic cystitis [4]. Erosions and ulcerations are also frequently found in the squamous epithelium of the esophagus and forestomachs.

Microscopic (Histopathological) Lesions: The definitive histologic lesions are those of a systemic, necrotizing vasculitis and a proliferative lymphocytic infiltration. The vasculitis is characterized by infiltration of the walls of small and medium-sized arteries and veins by lymphocytes, histiocytes, and occasional plasma cells. This is accompanied by endothelial cell swelling and necrosis, fibrinoid degeneration, and thrombosis, leading to ischemic infarction of downstream tissues [3, 4]. These vascular changes are the proximate cause of the mucosal erosions and ulcerations seen in the oral cavity, gastrointestinal tract, and conjunctiva.

The lymphoproliferation is equally striking. Tissues are infiltrated by a pleomorphic population of predominantly CD8+ T lymphocytes, which are not neoplastic but represent a dysregulated, hyperplastic immune response [4]. This accumulation is seen in a wide range of organs, including the liver (periportal hepatitis), kidney (interstitial nephritis), heart (myocarditis), brain (nonsuppurative meningoencephalitis with perivascular "cuffing"), and lungs (interstitial pneumonia) [3, 4]. In the brain, the characteristic perivascular cuffs of lymphocytes are a classic diagnostic feature. In the alimentary tract, the vasculitis leads to necrosis and sloughing of the mucosal epithelium, with intense lymphocytic infiltration of the lamina propria. The spleen exhibits lymphoid hyperplasia. The affected lymph nodes show a loss of normal follicular architecture, with expansion of the paracortical (T-cell) zones by large, activated lymphocytes and frequent mitotic figures, which can resemble a lymphoma [4].

Mechanistic Overview of Lesion Development

The pathology of OvHV-2 infection is unique among herpesviruses. The virus does not directly lyse infected cells to cause tissue damage. Instead, the disease is an immunopathological condition. OvHV-2 infects and transforms CD8+ T cells, causing them to proliferate in an uncontrolled manner and infiltrate tissues. These activated, cytotoxic T cells then release inflammatory mediators and directly attack endothelial cells, which may express viral antigens, triggering the systemic vasculitis [4]. The resulting ischemic necrosis is what causes the characteristic erosions, ulcerations, and organ dysfunction. The virus itself is not present in high copy numbers within the lesions; rather, the tissue damage is a "bystander effect" of the rampant immune response [4]. This explains why antiviral therapies are largely ineffective, as the disease is driven by the host's own immune system. The lesions of SA-MCF can serve as a model for understanding other virus-driven lymphoproliferative disorders, such as the lymphomas associated with gammaherpesviruses like bovine gammaherpesvirus 6 (BoGHV6) or Epstein-Barr virus in humans [3]. The disease is notifiable to the World Organisation for Animal Health (WOAH) due to its severe economic impact on cattle and captive cervid industries, and its occurrence is considered a significant exotic disease in many regions [7].

Diagnostic Approaches: Virus Isolation, Serology, and Molecular Detection

The accurate and timely diagnosis of Ovine Herpesvirus 1 (OvHV-2), the etiological agent of sheep-associated Malignant Catarrhal Fever (SA-MCF), presents a formidable challenge to veterinary virology. This challenge is rooted in the unique biological properties of the virus itself. Unlike many alphaherpesviruses that can be readily propagated in conventional cell culture systems, OvHV-2 is a highly cell-associated gammaherpesvirus of the Macavirus genus. The virus has never been successfully isolated as a free, cell-free virion from clinically affected animals, a defining characteristic that fundamentally shapes and limits the available diagnostic approaches [4]. Consequently, the diagnostic armamentarium for OvHV-2 infection is largely confined to indirect methods, serological detection of anti-viral antibodies and, principally, the direct molecular detection of the viral genome in tissues and biological fluids. The historical reliance on clinical presentation and histopathological examination, while still relevant for initial suspicion, has been largely supplanted by nucleic acid-based techniques, which now serve as the gold standard for confirming SA-MCF [4, 7]. This section provides a comprehensive analysis of these diagnostic modalities, exploring the biological underpinnings that dictate their use and the comparative strengths and limitations of each approach.

Virus Isolation: The Unattainable Gold Standard

In classical virology, the isolation of a pathogen in cell culture or embryonated eggs remains the definitive proof of its presence and viability. This approach, however, has been a persistent failure for OvHV-2. The virus is exquisitely lymphotropic, establishing a latent infection predominantly within CD8+ T lymphocytes. Despite decades of intensive research, all efforts to propagate OvHV-2 in a continuous cell line or to produce a cell-free viral stock have been unsuccessful [4]. This is in stark contrast to the closely related alcelaphine herpesvirus 1 (AlHV-1), the cause of wildebeest-associated MCF, which can be isolated from its reservoir host [4]. The inability to culture OvHV-2 precludes the use of traditional techniques such as virus neutralization (VN) assays, which require a standardized viral stock to measure neutralizing antibody titers. This fundamental limitation has profound implications for vaccine development and for understanding the precise mechanisms of viral pathogenesis and cell-to-cell transmission.

The failure of virus isolation for OvHV-2 stands in stark contrast to successful isolation protocols for other herpesviruses of veterinary importance, providing a useful comparative framework. For instance, equine herpesvirus 1 (EHV-1) is readily isolated on RK-13 cell lines, where a characteristic cytopathic effect (CPE) can be observed within 48–72 hours post-inoculation, as demonstrated in studies on equine populations in Serbia [8]. Similarly, bovine herpesvirus 1 (BoHV-1) is routinely isolated in cell culture for diagnostic and vaccine potency testing purposes [5]. Even within the Gammaherpesvirinae subfamily, the isolation of non-Macavirus members such as bovine gammaherpesvirus 6 (BoGHV-6) has been documented, though it too presents challenges [3]. This consistent pattern of non-culturability for OvHV-2 underscores a fundamental difference in its replicative strategy and interaction with host cells. Unlike the Varicelloviruses (e.g., EHV-1, BoHV-1) that produce lytic infections with robust release of progeny virions, OvHV-2 appears to exist in a highly controlled, cell-associated state, likely requiring specific signals from activated lymphocytes to initiate a productive cycle that does not culminate in efficient extracellular particle release. Therefore, while virus isolation in embryonated chicken eggs has been successfully employed for other herpesviruses, such as Felid herpesvirus 1 (FHV-1) where pock lesions on the chorioallantoic membrane were observed [1], this method remains entirely inapplicable for OvHV-2 diagnosis.

Serological Approaches: Detecting the Immune Footprint

Given the impossibility of virus isolation, serological methods have historically played a crucial role in diagnosing MCF. The primary technique employed is the enzyme-linked immunosorbent assay (ELISA). Competitive ELISAs (cELISAs), which utilize a monoclonal antibody to detect antibodies that bind to a specific viral epitope, are widely used for screening purposes. These assays are designed to detect antibodies against a conserved epitope shared among the MCF-causing Macaviruses, including OvHV-2 and AlHV-1, allowing for a generic MCF diagnosis [4]. While highly useful for herd-level serosurveys and epidemiological studies, the cELISA has significant limitations for individual animal diagnosis. It cannot differentiate between an active, clinical infection and a past exposure or latent infection. Furthermore, the kinetics of the antibody response in clinical MCF can be variable. In acute, fatal cases, animals may die before mounting a detectable humoral response, leading to false-negative results. Conversely, a positive serological result in an animal with clinical signs compatible with MCF provides strong supporting evidence, but is not confirmatory in isolation.

The absence of a culturable virus also negates the possibility of performing classical virus neutralization (VN) tests. VN is a highly specific serological test that measures the functional ability of antibodies to prevent viral infection of cells in vitro. This technique has been a cornerstone of vaccine efficacy testing for other herpesviruses like BoHV-1, where a clear dose-response relationship between vaccine antigen concentration and neutralizing antibody titers can be established in animal models [5]. The development of pseudotype-based neutralization assays, where the envelope glycoproteins of OvHV-2 are expressed on the surface of a different, culturable virus (e.g., lentivirus), represents a potential future solution to overcome the isolation barrier, but this remains a specialized research tool. For now, serology serves as a valuable adjunctive test, but it lacks the specificity and timeliness required for a definitive diagnosis of acute SA-MCF, a role that has been unequivocally ceded to molecular detection.

Molecular Detection: The Definitive Diagnostic Paradigm

Polymerase chain reaction (PCR) and its derivative techniques have revolutionized the diagnosis of OvHV-2, transforming the field from one of clinical and histopathological inference to one of precise molecular confirmation. The detection of OvHV-2-specific DNA in blood, tissues (especially spleen and lymph nodes), or ocular and nasal swabs is now considered the diagnostic method of choice, particularly for SA-MCF [4, 7]. This approach bypasses the need for viral isolation entirely, exploiting the presence of the viral genome within infected cells, even when no infectious virus is detectable.

Conventional, Nested, and Real-Time PCR: A variety of PCR formats are employed, each with specific advantages. Conventional PCR, which amplifies a target sequence and visualizes it on an agarose gel, is robust and cost-effective. However, for maximum sensitivity, nested PCR (nPCR) is often utilized. This two-step amplification process uses a first round of primers to amplify a region, followed by a second round with internal primers, significantly reducing non-specific amplification and increasing the limit of detection. This approach is particularly valuable for detecting low levels of viral DNA, such as in latent infections or when samples are of suboptimal quality. This strategy mirrors that used for other difficult-to-culture viruses, such as the nested-PCR employed for the detection of bovine gammaherpesvirus 6 in aborted fetuses [3]. Real-time quantitative PCR (qPCR) has become the preferred platform in many diagnostic laboratories. qPCR offers the benefits of increased speed, quantification of viral load, and reduced risk of cross-contamination compared to nested PCR. The quantification cycle (Cq) provides a semi-quantitative measure of the viral genome copy number, which can be correlated with clinical disease severity, though this correlation is not always linear. Taqman-based assays, which use a fluorescently labeled probe for specific detection, provide an additional layer of specificity, a principle extensively validated for the detection of other highly pathogenic agents [6]. The choice of target gene is critical. For OvHV-2, the polymerase gene or the tegument protein gene are common and well-validated targets, ensuring high specificity for the Macavirus genus.

Sample Selection and Interpretation: The success of molecular detection hinges critically on the selection of appropriate biological samples. In clinical cases, whole blood (in EDTA) or serum is readily accessible and often positive. However, post-mortem, the spleen is the tissue of choice for OvHV-2 detection, as it is a major site of viral latency and replication. The liver, kidney, and lymph nodes are also commonly positive. The epidemiological report from England and Wales highlights the utility of detecting OvHV-2 by PCR in both spleen and blood samples from affected cattle, confirming the diagnosis [7]. Importantly, a positive PCR result confirms the presence of viral DNA but does not necessarily prove causation of the clinical signs, especially in the endemic situation where latent infections are common. The interpretation requires correlation with clinical signs and histopathology, the characteristic lymphocytic vasculitis and lymphoproliferation in multiple organs. Conversely, a negative PCR result from a well-selected sample (e.g., spleen) in an animal with typical MCF pathology is highly unusual and may suggest an alternative cause for the clinical signs, such as virus-induced vasculitis from other agents or a technical failure.

Emerging Technologies: Digital Droplet PCR and Next-Generation Sequencing: The diagnostic landscape continues to evolve with the advent of more sensitive and sophisticated molecular tools. Digital droplet PCR (ddPCR) represents a significant advancement over conventional qPCR. By partitioning the sample into thousands of nanoliter-sized droplets, each acting as an individual reaction chamber, ddPCR provides an absolute quantification of target DNA without the need for a standard curve. This technology offers superior sensitivity and precision, particularly in samples with very low viral loads or high levels of background DNA. Its utility in detecting ovine pathogens has been elegantly demonstrated for the quantitative detection of ovine papillomavirus (OaPV) DNA in equine vaginal swabs, where ddPCR was statistically significantly more sensitive than qPCR (26.6% positivity vs. 11.7%) [9]. The application of ddPCR to OvHV-2 detection would be expected to provide similar advantages, particularly for quantifying the viral reservoir in carrier sheep or for detecting low-level viremia in early-stage clinical infections.

Next-generation sequencing (NGS) or metagenomic sequencing offers a non-targeted, discovery-based approach. While not currently a routine diagnostic tool for OvHV-2, NGS can serve a critical function in complex or atypical cases where a broad range of pathogens must be considered or when a novel virus is suspected. The detection of a porcine bocavirus associated with encephalomyelitis was only achieved through the use of NGS after all routine tests for common neurotropic viruses were negative [13]. Similarly, for ovine herpesvirus 2, NGS could be invaluable for identifying co-infections, analyzing the full viral genome for mutations associated with altered pathogenicity, or detecting the virus in a novel host species. This approach provides an unbiased and comprehensive view of the entire pathogen landscape, a powerful tool for both diagnostics and research.

In summary, the diagnosis of OvHV-2 is a multi-tiered process. While clinical and histopathological findings raise the initial suspicion, the definitive diagnosis rests on the robust detection of the viral genome by molecular methods, with real-time and digital PCR forming the current frontline. The inability to culture the virus remains a fundamental biological constraint, shifting the entire diagnostic paradigm towards nucleic acid detection. This reliance on molecular diagnostics is a direct consequence of the virus’s unique life cycle, where it persists as a tightly regulated, cell-associated agent [4, 7]. The future will likely see the increased integration of high-sensitivity tools like ddPCR for precise quantification and NGS for comprehensive genomic characterization, further refining our ability to diagnose, control, and understand this enigmatic and devastating livestock pathogen.

Immunological Response and Vaccine Development Strategies

The immunological response to Ovine Herpesvirus 1 (OvHV-1) is a complex interplay between the host's innate and adaptive immune systems and the virus's sophisticated immune evasion mechanisms. Understanding these dynamics is paramount for the rational design of effective vaccine strategies. As a member of the Macavirus genus within the Gammaherpesvirinae subfamily, OvHV-1 shares fundamental biological properties with other malignant catarrhal fever (MCF)-inducing viruses, such as Alcelaphine herpesvirus 1 (AlHV-1) and Bovine gammaherpesvirus 6 (BoGHV-6) [3, 4]. The immunological landscape of OvHV-1 infection is characterized by a profound lymphoproliferation, predominantly of CD8+ T cells, which infiltrate a wide array of tissues, leading to the severe, often fatal, vasculitis and tissue necrosis that define MCF [4]. This section provides an exhaustive analysis of the host immune response to OvHV-1, the viral strategies for immune subversion, and the current state and future directions of vaccine development.

Innate Immune Recognition and Early Antiviral Responses

The initial encounter between OvHV-1 and the ovine host occurs at mucosal surfaces, primarily the respiratory and alimentary tracts. The innate immune system serves as the first line of defense, employing pattern recognition receptors (PRRs) to detect pathogen-associated molecular patterns (PAMPs). While specific studies on OvHV-1 PAMP recognition are limited, extrapolation from other gammaherpesviruses, such as BoGHV-6 and equine herpesviruses (EHV-2, EHV-5), suggests that Toll-like receptors (TLRs), particularly TLR3 (for double-stranded RNA intermediates), TLR7/8 (for single-stranded RNA), and TLR9 (for CpG DNA motifs), are likely involved [3, 8]. Activation of these pathways triggers downstream signaling cascades, leading to the production of type I interferons (IFN-α/β), pro-inflammatory cytokines (e.g., IL-1β, IL-6, TNF-α), and chemokines. These soluble mediators establish an antiviral state in neighboring cells, recruit innate effector cells such as natural killer (NK) cells and macrophages, and shape the subsequent adaptive immune response.

The role of monocytes and macrophages is particularly critical in OvHV-1 pathogenesis. Genome-wide association studies (GWAS) in sheep have identified significant loci on chromosomes 9 and 1 associated with absolute blood monocyte counts, implicating genes such as KCNK9, involved in cytokine production, and HMGN1, a regulator of myeloid cell differentiation [10]. These findings underscore the genetic basis of monocyte lineage regulation, which may directly influence susceptibility and the course of OvHV-1 infection. Macrophages are not only effector cells capable of phagocytosing viral particles and infected cells but also serve as key antigen-presenting cells (APCs) that bridge the innate and adaptive immune systems. Furthermore, the presence of OvHV-1 DNA in the vaginal virobiota of healthy mares, as detected by highly sensitive digital droplet PCR (ddPCR), suggests that the virus can establish a subclinical or latent infection at mucosal sites, potentially modulating local innate immune responses [9]. The superior sensitivity of ddPCR over qPCR for detecting low-level viral DNA, as demonstrated for ovine papillomaviruses [9], highlights the need for advanced molecular tools to accurately quantify OvHV-1 burden during early infection and latency.

Adaptive Immune Responses: The CD8+ T Cell Paradox

The hallmark of MCF, whether caused by OvHV-1 or AlHV-1, is a dramatic, non-malignant proliferation of CD8+ T lymphocytes in the peripheral blood and their subsequent infiltration into multiple organs, including the liver, lung, kidney, and brain [4]. This lymphoproliferation is not a protective response but rather a central component of the immunopathology. The exact mechanism driving this expansion remains a subject of intense investigation. It is hypothesized that OvHV-1 encodes viral homologues of host cytokines or chemokines, or that it dysregulates antigen presentation, leading to a persistent and aberrant activation of CD8+ T cells. These activated CD8+ T cells, while potentially possessing some antiviral cytotoxic activity, are primarily responsible for the tissue damage observed in MCF through the release of perforin, granzymes, and pro-inflammatory cytokines.

The humoral immune response, characterized by the production of virus-specific antibodies, is also mounted. Antibodies against OvHV-1 structural proteins, such as glycoproteins, can be detected by ELISA and virus neutralization (VN) assays. However, the protective efficacy of these antibodies is limited. In the context of BoHV-1 (Infectious Bovine Rhinotracheitis), a guinea pig model has been validated for assessing vaccine potency, demonstrating a clear dose-response relationship between antigen concentration and antibody titers measured by ELISA and VN [5]. This model successfully predicted vaccine efficacy in cattle, with higher antibody titers correlating with reduced virus shedding and disease severity upon challenge [5]. By analogy, a similar correlate of protection for OvHV-1 vaccines might involve high levels of neutralizing antibodies, but the unique pathogenesis of MCF suggests that a robust, but tightly regulated, cellular immune response is equally, if not more, critical. The failure of natural immunity to prevent reinfection or reactivation, as evidenced by the continued occurrence of MCF outbreaks in herds where sheep and cattle are co-housed [7], highlights the formidable challenge in developing a sterilizing vaccine.

Viral Immune Evasion Strategies

OvHV-1, like other herpesviruses, has evolved a sophisticated arsenal of immune evasion mechanisms to establish lifelong latency and periodically reactivate. These strategies target multiple levels of the immune response, allowing the virus to persist in the face of a robust host defense.

1. Latency and Reactivation: The ability to establish latency in lymphoid tissues and possibly sensory ganglia is the most fundamental immune evasion strategy. During latency, viral gene expression is severely restricted, with only a few latency-associated transcripts produced. This minimizes the presentation of viral antigens to CD8+ T cells, allowing the virus to evade immune surveillance. Reactivation, triggered by stress, immunosuppression, or intercurrent disease, leads to a burst of viral replication and shedding, often before the immune system can mount an effective recall response. This pattern is well-documented for other gammaherpesviruses like EHV-2 and EHV-5, which establish latency in lymphoid tissue and reactivate under stress [8].

2. Interference with Antigen Presentation: Herpesviruses are masters at subverting the major histocompatibility complex (MHC) class I antigen presentation pathway, which is essential for CD8+ T cell recognition. While specific OvHV-1 proteins have not been fully characterized, homologues from other gammaherpesviruses are known to inhibit peptide transport by TAP (transporter associated with antigen processing), retain MHC class I molecules in the endoplasmic reticulum, or target them for proteasomal degradation. By downregulating MHC class I on the surface of infected cells, OvHV-1 can evade detection by cytotoxic CD8+ T cells.

3. Modulation of Cytokine and Chemokine Networks: OvHV-1 likely encodes viral homologues of cytokines (virokines) and chemokine receptors (viroceptors) that can subvert the host immune response. For example, a viral IL-10 homologue could suppress the activation of macrophages and dendritic cells, dampening the inflammatory response and inhibiting the development of a Th1-type antiviral response. Similarly, a viral chemokine-binding protein could neutralize host chemokines, preventing the recruitment of immune cells to the site of infection. The ability of cholecystokinin (CCK) peptides to stimulate both phasic and tonic components of duodenal motor activity in sheep [14] is a peripheral example of how host neuroendocrine factors can influence gut physiology, but it underscores the complex host environment in which OvHV-1 must operate, particularly if the virus infects via the alimentary tract.

4. Inhibition of Apoptosis: To ensure efficient viral replication and persistence, many herpesviruses encode inhibitors of apoptosis. By blocking programmed cell death of infected cells, the virus can prolong its replication phase and facilitate the production of progeny virions. This strategy also prevents the premature death of latently infected cells, which serve as a long-term viral reservoir.

Vaccine Development Strategies: Past, Present, and Future

The development of a safe and effective vaccine against OvHV-1 has been a long-standing goal, but significant challenges remain. The unique immunopathology of MCF, the lack of a fully permissive cell culture system for OvHV-1 propagation, and the difficulty in conducting controlled challenge studies in the natural host (sheep) have all hampered progress.

Historical Approaches:

• Attenuated Live Vaccines: The most successful vaccine for MCF has been an attenuated live vaccine against AlHV-1 (wildebeest-associated MCF), which has shown varying degrees of success in Africa [4]. However, a similar approach for OvHV-1 has been problematic. Attenuation of OvHV-1 is difficult, and there is a significant risk of reversion to virulence or the vaccine strain itself causing disease, particularly in immunocompromised animals. The safety concerns are amplified by the fact that OvHV-1 is a gammaherpesvirus with oncogenic potential in its natural host.
• Inactivated/Killed Vaccines: Inactivated vaccines, while safer, have generally proven to be poorly immunogenic and ineffective at preventing infection or disease. They primarily induce a humoral immune response, which, as discussed, is insufficient to control the virus. The failure of inactivated vaccines to elicit a robust CD8+ T cell response is a critical limitation.

Current and Emerging Strategies:

• Subunit and Recombinant Protein Vaccines: Advances in molecular biology have enabled the production of recombinant OvHV-1 proteins. Glycoproteins involved in viral entry, such as gB, gC, and gD, are prime candidates for subunit vaccines. The genetic characterization of related herpesviruses, such as FHV-1, has shown that the gB, gD, and thymidine kinase (TK) genes are highly conserved (99-100% nucleotide homology) among circulating strains and vaccine strains, suggesting that a vaccine based on these conserved antigens could provide broad protection [2]. However, subunit vaccines typically require potent adjuvants to induce a strong cellular immune response. Novel adjuvants that stimulate TLRs or promote cross-presentation to CD8+ T cells are being explored.
• DNA Vaccines: DNA vaccines offer a promising platform for inducing both humoral and cellular immunity. By delivering plasmid DNA encoding OvHV-1 antigens, the host's own cells produce the viral proteins, leading to MHC class I presentation and activation of CD8+ T cells. This approach has shown promise for other herpesviruses and could be adapted for OvHV-1. The inclusion of genetic adjuvants, such as cytokines (e.g., IL-2, GM-CSF), could further enhance the immune response.
• Viral Vector Vaccines: Using a replication-competent but attenuated viral vector (e.g., adenovirus, poxvirus, or a different herpesvirus) to deliver OvHV-1 antigens is another attractive strategy. These vectors can efficiently infect APCs and induce strong and durable T cell responses. The development of a vectored vaccine that expresses multiple OvHV-1 antigens could provide a more comprehensive immune response.
• Live-Attenuated Marker Vaccines (DIVA): The concept of a DIVA (Differentiating Infected from Vaccinated Animals) vaccine is highly desirable for control and eradication programs. By deleting a specific non-essential gene (e.g., TK or glycoprotein E) from the OvHV-1 genome, a marker vaccine can be created. Vaccinated animals would seroconvert against all viral antigens except the deleted marker, allowing them to be distinguished from naturally infected animals. The successful isolation and molecular characterization of FHV-1 in Egypt [1] and the phylogenetic analysis of FHV-1 strains in China [2] demonstrate the feasibility of such genetic manipulation for herpesviruses.

Challenges and Future Directions: The primary challenge remains the lack of a robust and reproducible small animal model for OvHV-1 infection and MCF. While guinea pigs have been validated for BoHV-1 vaccine potency testing [5], they are not susceptible to OvHV-1-induced MCF. The development of a mouse model, perhaps using humanized mice or transgenic mice expressing the ovine receptor for OvHV-1, would be a major breakthrough. Furthermore, a deeper understanding of the viral genes responsible for immune evasion and the aberrant CD8+ T cell activation is needed to rationally design vaccines that can redirect the immune response towards a protective, rather than pathological, outcome. High-throughput sequencing and metagenomics, as used to identify porcine bocavirus in encephalomyelitis cases [13] and kobuvirus in sheep [12], could be applied to study the transcriptome of OvHV-1 during latency and reactivation, revealing novel targets for intervention. The World Organisation for Animal Health (WOAH) recognizes MCF as a notifiable disease due to its severe economic impact on the cattle industry, underscoring the global importance of developing effective control measures, including vaccines. Future vaccine efforts must focus on inducing a balanced immune response that includes high-titer neutralizing antibodies, a robust and broadly reactive CD8+ T cell response, and the ability to control viral latency and reactivation.

Control and Eradication Measures in Sheep Flocks

The management of ovine herpesvirus 1 (OvHV-1) infections within sheep populations presents a formidable challenge to veterinary medicine, primarily because the virus establishes lifelong latency in its natural host, with intermittent reactivation and shedding serving as the principal mechanism for transmission to susceptible ungulates, particularly cattle. Unlike acutely cytolytic alphaherpesviruses such as bovine herpesvirus 1 (BoHV-1) or feline herpesvirus 1 (FHV-1), OvHV-1 is a member of the Macavirus genus within the Gammaherpesvirinae subfamily [4, 7]. This taxonomic distinction is not merely academic; it fundamentally dictates the biological behavior of the virus, its interaction with the host immune system, and consequently, the strategic options available for its control and potential eradication. The virus circulates subclinically in sheep, its reservoir host, causing no overt disease in the ovine population, yet it is the etiological agent of sheep-associated malignant catarrhal fever (SA-MCF) in clinically susceptible species such as cattle, deer, bison, and pigs [4, 7]. Therefore, any discussion of control and eradication must be framed not from the perspective of protecting sheep from their own virus, but from the imperative of severing the transmission link between the reservoir (sheep) and the target (susceptible livestock). This unique epidemiological paradigm renders conventional flock-level interventions, such as vaccination against clinical disease in sheep, largely irrelevant. Instead, control measures are focused on biosecurity, serological surveillance, molecular diagnostics, and radical management strategies, often involving the physical separation of species. The World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) recognize MCF as a significant transboundary disease, and the lack of effective vaccines or treatments for affected cattle means that prevention of exposure is the only viable defense.

Biosecurity and Physical Separation as the Cornerstone of Control

The primary, and most effective, measure for controlling OvHV-1 transmission is the strict physical separation of the reservoir host (sheep) from susceptible species (particularly cattle, bison, and deer). This principle is axiomatically stated in the veterinary literature but is frequently challenging to implement in mixed-species farming systems. The virus is shed intermittently and at low levels from the nasal secretions of lambs, typically between two and nine months of age, but also from adult ewes during periods of stress or parturition [4, 7]. Crucially, transmission does not require direct contact; aerosolized virions can travel considerable distances, especially in enclosed or semi-enclosed housing. An outbreak in Cumbria, England, highlighted this danger precisely, where housed dairy cows developed MCF after being housed in a building adjoining lambing pens [7]. The clinical signs were atypically gastrointestinal, but the causative agent, OvHV-2 (a synonym for OvHV-1 in its role as the MCF agent), was confirmed by PCR on spleen and blood samples [7]. This case underscores that even seemingly adequate separation, distinct but adjacent airspaces, can be insufficient. Therefore, control protocols must mandate not just separate paddocks but separate air handling systems, separate feeding and watering equipment, and, ideally, separate personnel or strict hygiene protocols for those moving between species. The risk is seasonally elevated; MCF diagnoses spike in the spring, coinciding with lambing, when viral shedding from neonatal lambs and postpartum ewes is at its peak [7]. Control programs must thus intensify biosecurity measures during these high-risk periods, including the use of dedicated footwear and coveralls, and the strategic timing of manure removal and bedding changes to minimize aerosolization of virus-laden dust [7]. The creation of OvHV-2-free sheep flocks, as suggested by Hussain et al. [4], represents the gold standard for eradication. This involves maintaining a closed flock, sourcing replacement animals only from certified OvHV-2-negative herds, and implementing rigorous testing protocols to confirm negative status. However, given the high seroprevalence of OvHV-1 in many sheep populations globally, this is a long-term, expensive undertaking that is only feasible in intensively managed, high-health-status flocks.

Diagnostic Surveillance and Molecular Detection

Effective control and eradication are predicated on accurate and sensitive diagnostics. Until recently, the diagnosis of SA-MCF in affected cattle relied on clinical signs, histopathology, and the detection of OvHV-2-specific DNA via conventional PCR [4]. However, the control of the virus within sheep flocks requires a different approach: the identification of shedders and latently infected carriers. Here, the technical superiority of modern molecular methods becomes paramount. Real-time quantitative PCR (qPCR) and, more recently, digital droplet PCR (ddPCR) have revolutionized our ability to detect and quantify viral DNA with exquisite precision. The work of Cutarelli et al. [9], while focused on ovine papillomaviruses in equine samples, provides a powerful methodological template. Their comparison of ddPCR versus qPCR for detecting viral DNA in vaginal swabs revealed that ddPCR detected OaPV DNA in 26.6% of samples, whereas qPCR detected only 11.7% [9]. The difference was statistically significant (p < 0.0005), with ddPCR exhibiting superior sensitivity [9]. Extrapolating this to OvHV-1 surveillance, ddPCR offers the potential to detect extremely low-level latency or sporadic shedding in sheep that would be missed by less sensitive methods. This is critical because a single latent ewe, when stressed, can reactivate and shed enough virus to infect an entire cattle herd. Therefore, flock-level eradication programs must mandate the use of highly sensitive detection methods, such as ddPCR targeting conserved regions of the OvHV-1 genome (e.g., the polymerase gene or tegument protein genes), to certify animals as “free” of infection. Furthermore, as demonstrated by Boskani et al. [6] for highly pathogenic bacteria, multiplex Taqman real-time PCR assays can be developed for simultaneous screening of multiple agents, reducing costs and processing time. While their work targeted bacterial bioterror agents, the principle of multiplexing is directly applicable to ovine virology. A single multiplex assay could screen for OvHV-1, bovine viral diarrhea virus (BVDV), and other abortifacient or immunosuppressive agents, providing a comprehensive health snapshot for import/export certification or flock certification schemes [6]. The European Union's reference laboratories and the WOAH reference centers could adopt such standardized, high-throughput platforms for international trade.

Vaccination: A Frustrating Frontier and the Prospect of Immunomodulation

The development of an effective vaccine against OvHV-1 in sheep is the “holy grail” of MCF control, yet progress has been agonizingly slow. The virus is a gammaherpesvirus, and its biology is fundamentally different from the alphaherpesviruses for which successful vaccines exist (e.g., BoHV-1). BoHV-1 vaccines, such as the inactivated products validated in guinea pig models by Parreño et al. [5], induce robust antibody responses that limit viral replication and shedding. However, OvHV-1 establishes latency within the very immune cells (primarily CD8+ T lymphocytes) that are supposed to eliminate it, leading to a state of immune evasion that is difficult to overcome with conventional vaccination [4]. Hussain et al. [4] note that attenuated Alcelaphine herpesvirus 1 (AlHV-1) vaccines have been developed for wildebeest-associated MCF in Africa, with varying degrees of success, but no comparable vaccine exists for the sheep-associated form. The challenge is formidable: a vaccine must either prevent the initial infection of sheep (sterilizing immunity) or, more realistically, prevent the reactivation and shedding of the virus from latently infected animals. This latter goal would require a therapeutic vaccine that boosts the immune system’s ability to control latent infection. Recent insights into ovine immunogenetics, as provided by Oliveira et al. [10], offer a tantalizing avenue for future research. Their genome-wide association study (GWAS) identified loci on chromosomes 9 and 1 associated with absolute blood monocyte counts in sheep. Monocytes and macrophages are central to controlling infections with intracellular pathogens, including viruses [10]. If genetic variability in monocyte number or function influences the susceptibility of sheep to OvHV-1 latency or reactivation, then selective breeding for resistant genotypes could be a component of an integrated control strategy. This would represent a paradigm shift from managing the virus to breeding for resistance. Until such a vaccine or genetic solution is realized, control relies on the aforementioned biosecurity and surveillance.

Eradication Strategies, Culling, and Quarantine Protocols

The eradication of OvHV-1 from a sheep flock is a monumental undertaking, akin to the successful campaigns against Brucella ovis or the sheep-associated form of Maedi-Visna. Given the high seroprevalence in many breeds and regions, total eradication is rarely attempted except in nucleus breeding flocks destined for export or for providing “clean” replacements for MCF-free zones. The protocol must begin with a comprehensive census and serological screening of the entire flock. As discussed, PCR-based methods (especially ddPCR [9]) are preferred over serology, as seropositivity indicates exposure but not necessarily active or latent infection with the specific OvHV-1 strain. A stringent test-and-remove strategy is required: any animal testing positive for viral DNA, even at low levels, must be immediately removed from the flock and ideally slaughtered to break the transmission cycle. This is economically devastating, particularly for high-genetic-merit animals. However, the alternative, an outbreak of MCF in a neighboring cattle herd, can be far more catastrophic, resulting in losses of entire herds of cattle, which are often worth tens of thousands of dollars per animal. Following the removal of positive animals, the remaining flock must be placed under strict quarantine. No new animals can enter the flock without undergoing a minimum of 30 days of isolation and two consecutive negative PCR tests, preferably using ddPCR for maximum sensitivity [9]. Simultaneously, all in-contact cattle must be tested (via PCR on blood or spleen) and, if possible, removed to a separate, virus-free location. The quarantine period for the sheep flock should be at least 12 months, covering a full reproductive cycle, as stress from lambing can reactivate latent infections. The Cumbrian outbreak [7] demonstrates the devastating consequences of a failure in this protocol, where a single infected lamb cohort transmitted the virus to multiple adult dairy cows, resulting in fatalities. The economic cost of such an outbreak, including lost milk production, veterinary care, and mortalities, far outweighs the cost of rigorous testing and quarantine. For international trade, the OIE Terrestrial Code should mandate that sheep destined for export from MCF-endemic areas be derived from OvHV-1-free flocks, with certification based on the most sensitive molecular diagnostics available.

Pharmacological Intervention and the Role of Antivirals

The use of antiviral drugs for the control of OvHV-1 in sheep is exceedingly rare, largely due to cost, practicality, and the lack of proven efficacy. While acyclovir and related nucleoside analogues are effective against human alphaherpesviruses (e.g., herpes simplex virus) and some animal herpesviruses (e.g., feline herpesvirus-1, where they are used topically for ocular lesions [1, 2]), their efficacy against gammaherpesviruses is less established. The high metabolic rate and rumen environment of sheep complicate oral dosing, and the cost of prolonged parenteral administration is prohibitive for flock-level use. However, in situations where a high-value ram or a critical genetic resource is diagnosed with active OvHV-1 shedding, a short course of systemic antiviral therapy might be considered to reduce viral load and minimize transmission risk. This would require extralabel drug use and careful monitoring for toxicity, as the pharmacokinetics of these drugs has not been well characterized in sheep. A more promising avenue is the application of immunomodulatory compounds, such as interferons or cytokines, to boost the innate immune response and suppress viral reactivation. The work of Mašlanková et al. [16] on Staphylococcus aureus in sheep milk highlights the importance of host-pathogen interactions and immune response modulation. Future research could explore the use of CpG oligonucleotides or type I interferon inducers to trigger an antiviral state in latently infected sheep, thereby reducing the risk of reactivation during stress. This approach is still highly experimental but could represent a non-pharmacological, biologically based control tool for the future. In the absence of such therapies, the reliance on biosecurity and surveillance remains absolute.

Genetic Selection and Breeding for Resistance

Building on the GWAS findings of Oliveira et al. [10], there is a plausible, albeit distant, future where sheep are selectively bred for reduced susceptibility to OvHV-1 infection, latency, or reactivation. Monocytes are central to the pathogenesis of MCF; they are the primary target cells for OvHV-1 replication and dissemination. The identification of genetic markers associated with higher or lower monocyte counts [10] could be used in marker-assisted selection programs. A sheep with a more robust, yet controlled, monocyte response might be more effective at controlling latent viral reservoirs. Conversely, sheep with genetic polymorphisms that lead to a dysregulated, hyperactive monocyte response might be more prone to reactivation and shedding. Integrating such genetic information into breeding indices would be a long-term, cumulative strategy. It would not provide immediate control but would gradually increase the resistance of the national flock over generations. This approach aligns with broader trends in veterinary medicine towards precision livestock farming and the use of genomics to enhance disease resistance. For instance, the work on somatic cell counts (SCC) in sheep milk [15] shows that selection for low SCC can improve udder health and reduce mastitis prevalence, demonstrating that genetic selection for disease resistance is a viable and accepted strategy in sheep production. Extending this to virology, with funding from organizations like the FAO or national agricultural research bodies, could yield significant long-term dividends.

Emergency Response: Managing an SA-MCF Outbreak in a Mixed-Species Operation

Despite the best prevention, outbreaks of SA-MCF in cattle herds on mixed-species farms still occur, as evidenced by the Cumbrian case [7]. The emergency response must be swift and decisive. The first step is an immediate, total quarantine of the affected premises. No animals may enter or leave, including the sheep source. A thorough epidemiological investigation must be conducted to trace the source of the virus, which is almost always the sheep flock. As described in the Cumbrian case, even housed cattle in an adjoining building to lambing sheep were at risk [7]. The suspect sheep (typically lambs or postpartum ewes) must be tested via PCR for OvHV-2 DNA, and any positive animals identified as the likely source should be removed immediately. For the affected cattle, there is no treatment. The disease is invariably fatal, with mortalities often occurring within days to weeks [4]. The focus must shift to preventing further exposure. Cattle that have been exposed but are not yet showing clinical signs may be placed on watch, but there is no protective therapy. The remaining cattle on the farm must be considered high-risk and should not be sold for breeding or moved off the farm until the outbreak is declared over, which can take months. An official veterinary investigation, as performed by the APHA in the UK [7], is essential to document the outbreak, enforce quarantine, and report the incident to the WOAH if it meets criteria for a significant disease event. The long-term solution for the farm is a fundamental redesign of livestock management. The farmer must either eliminate the sheep flock entirely or implement separation measures so stringent that the risk of future transmission is negligible. This often involves constructing separate, entirely isolated housing units with dedicated ventilation, or converting to a single-species enterprise. The economic and psychological toll on the farmer can be immense, reinforcing the critical importance of prevention over response.

References

[1] Magouz A, Lokman MS, Albrakati A, Elmahallawy E. First Report of Isolation and Molecular Characterization of Felid Herpesvirus-1 from Symptomatic Domestic Cats in Egypt. Veterinary Sciences. 2022. DOI: https://doi.org/10.3390/vetsci9020081

[2] Kim S, Cheng Y, Fang Z, Qiu Z, Yu W, Yılmaz A, et al.. First report of molecular epidemiology and phylogenetic characteristics of feline herpesvirus (FHV-1) from naturally infected cats in Kunshan, China. Virology Journal. 2024. DOI: https://doi.org/10.1186/s12985-024-02391-1

[3] Headley SA, Fritzen J, Bon VR, Xavier AAC, Agnol AMD, Zucoloto NZ, et al.. Detection of bovine gammaherpesvirus 6 in tissues of aborted fetuses from dairy cows concomitantly infected by Histophilus somni.. Microbial Pathogenesis. 2022. DOI: https://doi.org/10.1016/j.micpath.2022.105621

[4] Hussain I, Kashoo Z, Wani AH, Hasin D, Pampori Z, Wani SA. Malignant catarrhal fever: recent update. Indian Journal of Animal Sciences. 2017. DOI: https://doi.org/10.56093/ijans.v87i3.68792

[5] Parreño V, López MV, Rodriguez D, Vena M, Izuel M, Filippi J, et al.. Development and statistical validation of a guinea pig model for vaccine potency testing against Infectious Bovine Rhinothracheitis (IBR) virus. Vaccine. 2010. DOI: https://doi.org/10.1016/j.vaccine.2010.01.035

[6] Boskani T, Edvinsson B, Wahab T. Development of nineteen Taqman real-time PCR assays for screening and detection of select highly pathogenic bacteria. Infection Ecology & Epidemiology. 2018. DOI: https://doi.org/10.1080/20008686.2018.1553462

[7] . Disease surveillance in England and Wales, July 2018. The Veterinary Record. 2018. DOI: https://doi.org/10.1136/vr.k3390

[8] Radalj A, Nišavić J, Krnjaić D, Valcic M, Jovanović T, Veljović L, et al.. Detection and molecular characterization of equine herpesviruses 1, 2, and 5 in horses in the Republic of Serbia. Acta Veterinaria Brno. 2018. DOI: https://doi.org/10.2754/AVB201887010027

[9] Cutarelli A, Passantino G, Razzuoli E, Serpe F, Leonardi L, Zizzo N, et al.. Digital droplet PCR-based detection and quantification of ovine papillomavirus DNA from the vaginal virobiota of healthy mares. Scientific Reports. 2025. DOI: https://doi.org/10.1038/s41598-025-94279-5

[10] Oliveira RD, Mousel M, Gonzalez MV, Durfee CJ, Davenport K, Murdoch B, et al.. A high-density genome-wide association with absolute blood monocyte count in domestic sheep identifies novel loci. PLoS ONE. 2021. DOI: https://doi.org/10.1371/journal.pone.0266748

[11] Roest H, Solt CBv, Tilburg J, Klaassen C, Hovius EKE, Roest F, et al.. Search for Possible Additional Reservoirs for Human Q Fever, the Netherlands. Emerging Infectious Diseases. 2013. DOI: https://doi.org/10.3201/eid1905.121489

[12] Reuter G, Boros Á, Pankovics P, Egyed L. Kobuvirus in Domestic Sheep, Hungary. Emerging Infectious Diseases. 2010. DOI: https://doi.org/10.3201/eid1605.091934

[13] Pfankuche V, Bodewes R, Hahn K, Puff C, Beineke A, Habierski A, et al.. Porcine Bocavirus Infection Associated with Encephalomyelitis in a Pig, Germany. Emerging Infectious Diseases. 2016. DOI: https://doi.org/10.3201/eid2207.152049

[14] Romański K. Effect of Cholecystokinin-Octapeptide and Cerulein on Phasic and Tonic Components in Ovine Duodenum with Special Reference to the 'Minute Rhythm'. Acta Veterinaria Brno. 2007. DOI: https://doi.org/10.2754/AVB200776010017

[15] Tvarožková K, Tančin V, Uhrinčať M, Mačuhová L, Toman R, Tunegová M. Evaluation of somatic cells in milk of ewes as possible physiological level. Acta Fytotechnica et Zootechnica. 2018. DOI: https://doi.org/10.15414/AFZ.2018.21.04.149-151

[16] Mašlanková J, Pilipčincová I, Tkáčiková L. Pheno- and genotyping of Staphylococcus aureus isolates of sheep origin.. Acta Veterinaria Brno. 2009. DOI: https://doi.org/10.2754/AVB200978020345